Roche Holding AG (RHHBY)


Other OTC - Other OTC Delayed Price. Currency in USD
30.79-0.19 (-0.63%)
At close: 3:59 PM EDT
People also watch:
NVSSNYNSRGYAZNBAYRY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open31.00
Prev Close30.99
Bid0.00 x
Ask0.00 x
Day's Range30.65 - 31.26
52wk Range29.89 - 35.13
1y Target EstN/A
Market Cap209.9B
P/E Ratio (ttm)22.32
Beta0.60
Volume1,229,396
Avg Vol (3m)1,027,752
Dividend & Yield1.02 (3.31%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • InPlay from Briefing.com
    Briefing.com15 minutes ago

    InPlay from Briefing.com

    InPlay from Briefing.com

  • PR Newswire2 hours ago

    Roche receives FDA Emergency Use Authorization for Zika PCR test

    OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the LightMix® Zika rRT-PCR Test.  The product is for use in patients meeting CDC Zika virus clinical criteria and/or CDC Zika virus epidemiological criteria. The test is used for the detection of Zika virus in EDTA plasma or serum samples using Roche's LightCycler® 480 Instrument II or cobas z 480 Analyzer.

  • New Zika Screening Rule Could Boost Hologic Sales Growth
    Investor's Business Daily2 days ago

    New Zika Screening Rule Could Boost Hologic Sales Growth

    The advisory that all U.S. blood centers screen for Zika is good news for Hologic's Procleix test.